1) I don't really understand what you mean, why would the public have anything to do with FDA decisions.
2) I absolutely give ODAC cred. The therapy has promise, they want to use it. They recognise that potency assays are tough with these sorts of cells.
It's the FDAs responsibility to make sure a safe, effective product is released. They obviously put more weight on the issues with the potency assays than ODAC.
3. They haven't proved that the cells work yet, but the data is interesting and promising. More studies should be done. That's how science works.
I hope that clears up my stance.
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2021 - paradigm shift
MSB Trading 2021 - paradigm shift, page-7828
-
-
- There are more pages in this discussion • 2,383 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $4.567M | 3.874M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 39274 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 27640 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 26141 | 1.160 |
16 | 57735 | 1.155 |
16 | 115841 | 1.150 |
13 | 204738 | 1.145 |
9 | 199738 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 121288 | 16 |
1.170 | 75989 | 12 |
1.175 | 62829 | 11 |
1.180 | 77071 | 11 |
1.185 | 13924 | 3 |
Last trade - 14.28pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online